Regeneron Pharmaceuticals

Get in the Ideas Business.
At Regeneron we believe that when the right idea finds the right team, powerful change is possible.
As we work together to discover, invent, and develop biopharmaceutical medicines, we’re creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health.
So connect with us. Tell us about you. Learn more about our life-changing medicines. And join us, as we build a future we believe in.

Company Growth (employees)
Type
Public
HQ
Tarrytown, US
Founded
1988
Size (employees)
5,400 (est)
Regeneron Pharmaceuticals was founded in 1988 and is headquartered in Tarrytown, US

Regeneron Pharmaceuticals Office Locations

Regeneron Pharmaceuticals has offices in Tarrytown, Rensselaer, Bernards, Limerick and in 1 other location
Tarrytown, US (HQ)
777 Old Saw Mill River Rd
Dublin, IE
Harcourt Centre Harcourt St
Bernards, US
110 Allen Rd
Rensselaer, US
81 Columbia Turnpike

Regeneron Pharmaceuticals Financials and Metrics

Regeneron Pharmaceuticals Financials

Regeneron Pharmaceuticals's revenue was reported to be $1.3 b in Q1, 2017
USD

Revenue (Q1, 2017)

1.3 b

Gross profit (Q1, 2017)

1.3 b

Gross profit margin (Q1, 2017), %

95%

Net income (Q1, 2017)

248.9 m

EBIT (Q1, 2017)

430.5 m

Market capitalization (12-Oct-2017)

51.9 b

Cash (31-Mar-2017)

811.8 m
Regeneron Pharmaceuticals's current market capitalization is $51.9 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.1 b2.8 b4.1 b4.9 b

Revenue growth, %

34%46%18%

Cost of goods sold

118 m129 m241.7 m194.6 m

Gross profit

2 b2.7 b3.9 b4.7 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

665.7 m725.8 m869.6 m998.6 m1.1 b1.2 b1.2 b1.2 b1.3 b

Cost of goods sold

29.9 m33.7 m42.6 m60.9 m67.2 m78.9 m41.2 m29.9 m61.3 m

Gross profit

635.8 m692.1 m827 m937.8 m1.1 b1.1 b1.2 b1.2 b1.3 b

Gross profit Margin, %

96%95%95%94%94%93%97%98%95%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

535.6 m648.7 m809.1 m535.2 m

Inventories

70.4 m128.9 m238.6 m399.4 m

Current Assets

1.8 b2.2 b2.9 b3.2 b

PP&E

2.1 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

600.1 m646.6 m507.9 m390.6 m654.6 m604.2 m646.5 m920.4 m811.8 m

Inventories

109.9 m120.3 m133.9 m171.3 m190.7 m303.3 m316.1 m345.6 m466.6 m

Current Assets

1.9 b2.2 b2.3 b2.3 b2.7 b3.1 b3.2 b3.5 b3.7 b

PP&E

1.7 b1.8 b1.9 b2.3 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

424.4 m348.1 m636.1 m895.5 m

Depreciation and Amortization

41.2 m52.7 m74.9 m104.7 m

Inventories

(48 m)(61 m)(110 m)(149.8 m)

Cash From Operating Activities

583.6 m743.2 m1.3 b1.5 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

158.2 m237.9 m76 m270.7 m481.1 m165.7 m377.6 m642.4 m248.9 m

Depreciation and Amortization

24.5 m38.6 m16 m31.3 m52 m23 m48 m75.8 m38.1 m

Inventories

(37.3 m)(50.9 m)(5.9 m)(49.9 m)(81.5 m)(62.3 m)(72.9 m)(99.7 m)(69.7 m)

Cash From Operating Activities

381.3 m544.9 m(87.5 m)156.1 m1 b29.3 m444.5 m1.1 b355.9 m
USDY, 2017

Revenue/Employee

244.3 k

Financial Leverage

1.6 x
Show all financial metrics

Regeneron Pharmaceuticals Market Value History

Regeneron Pharmaceuticals Median Salaries

Source: 186 public H-1B filings from Regeneron Pharmaceuticals

Traffic Overview of Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Online and Social Media Presence

Regeneron Pharmaceuticals Company Life and Culture

You may also be interested in